Amylin Pharma (AMLN) Reports Q4 GAAP Loss of $3.15/Share
Tweet Send to a FriendGet Alerts AMLN Hot Sheet
Price: $30.98 --0%
EPS Growth %: +4.2%
Financial Fact:
Total costs and expenses: 208.02M
Today's EPS Names:
GASS, AAP, RMCF, More
EPS Growth %: +4.2%
Financial Fact:
Total costs and expenses: 208.02M
Today's EPS Names:
GASS, AAP, RMCF, More
Trade AMLN Now!
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) reported Q4 GAAP loss of $3.15, which does not compare to the analyst estimate of ($0.08). The company posted a loss per share of 13 cents during the same quarter last year. Revenue for the quarter came in at $164.9 million versus the consensus estimate of $163.64 million.
For earnings history and earnings-related data on Amylin Pharmaceuticals, Inc. (AMLN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Amylin Pharmaceuticals, Inc. (AMLN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Signet Jewelers (SIG) Tops Q1 EPS Views; Comsp Up 6.4%; Guides Q2 EPS
- Dollar Tree, Inc. (DLTR) Tops Q1 EPS by 2c; Issues Muted Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
